These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 4846541

  • 1. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J, Pawlowski L, Sarnek J.
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract] [Full Text] [Related]

  • 2. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S, Cerletti C.
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract] [Full Text] [Related]

  • 3. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK, Sonninen V, Riekkinen P, Laaksonen H.
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract] [Full Text] [Related]

  • 4. The action of L-dopa in rats with the raphe nuclei lesions.
    Maj J, Przewlocka B.
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):151-4. PubMed ID: 1208224
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and animal experiments concerning the function of brain catecholamines.
    Matussek N.
    Int Pharmacopsychiatry; 1971 Oct; 6(3):170-86. PubMed ID: 4950569
    [No Abstract] [Full Text] [Related]

  • 6. Brain serotonin metabolism after tolerance dosage of LSD.
    Freedman DX, Boggan WO.
    Adv Biochem Psychopharmacol; 1974 Oct; 10():151-7. PubMed ID: 4846536
    [No Abstract] [Full Text] [Related]

  • 7. Central D-fenfluramine action.
    Mogilnicka E, Maj J, Pawlowski L, Garncarczyk L.
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):161-6. PubMed ID: 1082127
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The action L-dopa on sexual behaviour of male rats.
    Da Prada M, Carruba M, Saner A, O'Brien A, Pletscher A.
    Brain Res; 1973 Jun 15; 55(2):383-9. PubMed ID: 4541349
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ, Porter CC.
    J Pharmacol Exp Ther; 1970 Apr 15; 172(2):406-15. PubMed ID: 5441162
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
    Osborne MW, Wenger JJ, Willems W.
    J Pharmacol Exp Ther; 1971 Sep 15; 178(3):517-28. PubMed ID: 5571901
    [No Abstract] [Full Text] [Related]

  • 16. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
    Bartholini G, Da Prada M, Pletscher A.
    J Pharm Pharmacol; 1968 Mar 15; 20(3):228-9. PubMed ID: 4385052
    [No Abstract] [Full Text] [Related]

  • 17. L-DOPA: centrally mediated emission of seminal fluid in male rats.
    Friedman E, Gershon S.
    Life Sci I; 1972 May 01; 11(9):435-40. PubMed ID: 4656863
    [No Abstract] [Full Text] [Related]

  • 18. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
    Weiss BF, Roel LE, Munro HN, Wurtman RJ.
    Adv Neurol; 1974 May 01; 5():87-99. PubMed ID: 4155238
    [No Abstract] [Full Text] [Related]

  • 19. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM, Parks LC, Kopin IJ.
    J Clin Invest; 1971 Jun 01; 50(6):1322-8. PubMed ID: 5578236
    [Abstract] [Full Text] [Related]

  • 20. The effect of maprotiline on brain serotonin metabolism in rats.
    Benesová O, Benes V.
    Act Nerv Super (Praha); 1974 Aug 01; 16(3):190-1. PubMed ID: 4419548
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.